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Abstract
Objective
Joint fibrosis affects many synovial joints (including hip, knee and shoulder) causing stiff-
ness and pain. The mechanism of joint fibrosis remains unknown, although genetic factors
may contribute. Defects in maintenance of telomere length resulting from impaired telomere
repair have been shown to cause lung and liver fibrotic disease. Here we tested the hypothe-
sis that joint fibrosis and other soft tissue fibrotic conditions are also associated with telo-
mere length.
Patients and methods
5,200 participants in the TwinsUK registry had data on telomere length (measured by
qPCR) and the traits of interest (hip and knee stiffness, total joint replacement (TJR, hip or
knee) and fibrotic conditions (Dupuytren’s disease, frozen shoulder).
Results
Multivariable logistic regression analyses showed a significant association between telo-
mere length and fibrotic conditions (hip stiffness, knee stiffness and frozen shoulder,
p =0.002) even after taking age into account. No association was found between TJR and
telomere length.
Conclusion
These findings suggest that defects in telomere repair contribute to joint fibrosis, and that
fibrosis shares a common mechanistic pathway in different organs. Therapeutic strategies
to combat telomere shortening may offer novel treatments for fibrotic joint disease.
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Introduction
Using the TwinsUK registry of monozygotic and dizygotic twins [1], we have recently found a
significant association between fibrotic soft tissue conditions, joint stiffness and total joint
arthroplasty [2]. Fibrotic soft tissue conditions (frozen shoulder, Dupuytren’s disease, reported
hip and knee joint stiffness) appear to be polygenic disease traits with a heritability of ~40%
[2]. However, the molecular mechanisms driving joint fibrosis remain unknown and thera-
peutic options are extremely limited [3,4].
The process of fibrosis is characterized by the deposition of a dense, disorganized extracel-
lular matrix of collagen [5]. In fibrotic conditions affecting the joints, such as adhesive capsuli-
tis [6] and joint fibrosis [7], this manifests itself as joint stiffness, which is hugely debilitating
and adversely affects quality of life. Whilst the aetiology is multifactorial, it is likely that differ-
ent genetic and environmental triggers converge on a ‘common pathway’, involving α-smooth
muscle actin containing myofibroblasts, TGF-1β signaling and rapid deposition and tension-
ing of the new matrix [8]. To date, treatment strategies have largely focused on debridement
and/ or distension of the extracellular matrix. However, the underlying pathogenic mecha-
nisms of disease are not understood and thus targeted treatment has not yet been developed
[3,4].
Recent research suggests that defects in telomere maintenance involving the telomerase
reverse transcriptase (TERT) gene cause liver and lung fibrotic disease [9]. It is unclear at pres-
ent whether the joint soft tissue fibrosis is also telomere-mediated. Using telomere length and
existing information in the TwinsUK database we tested the hypothesis that soft tissue fibrosis
shares common telomere related aetiology as telomere-related lung and liver fibrosis.
Patients and methods
Participants were selected from the TwinsUK registry [10] on the availability of data from four
different questionnaires and clinical visits between 1992 and 2008. TwinsUK is the UK’s largest
registry of monozygotic (MZ) and dizygotic (DZ) twins. It contains extensive genotype and
phenotype data obtained at clinical visits and by mailed and online questionnaires. The twin
characteristics have been shown to be similar to the general singleton population for a range of
traits and lifestyle factors [10]. Responses to the questions ‘Have you ever had pain or stiffness
in the following joints? left knee/right knee/left hip/right hip’; ‘have you undergone a total
knee or total hip replacement?’; and ‘been diagnosed with frozen shoulder or Dupuytren’s con-
tracture?’ (fibrotic conditions) were extracted. Age, sex and body mass index (BMI) were also
extracted for the time-point relevant to each questionnaire. Non-respondents for each particu-
lar condition were considered not to have the condition, and were coded as negatives. This
standard data-handling practice in the TwinsUK dataset precludes descriptive analysis of
‘non-responders’. Participants were not aware of a specific hypothesis related to joint stiffness
or joint replacement being tested in this study, nor was the temporal relationship of the traits
explored. Ethics committee approval for the study was obtained from St Thomas’ Hospital
Ethical Review Board. All participants gave written, informed consent. King’s College Hospital
approved the consent procedure.
Telomere length
Mean leukocyte telomere length (LTL) was measured using a qPCR-based technique as part of
a larger study using the TwinsUK cohort as previously described [11]. Full details of the
method are included in Supplementary Information 1 (S1 Method). This method expresses
telomere length as a ratio (T/S) of telomere repeat length (T) to copy number of a single copy
gene (S), in each sample. To standardise across plates, either a calibrator sample or a standard
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curve was used for quantification. Mean LTL was first assessed for age-related shortening and
for an association of longer LTL with female sex in all cohorts, and showed expected associa-
tions. LTLs were standardised using a Z-score transformation and adjusted for age and sex. To
reduce the site-dependent effect one telomere length all measurements in this cohort were
made in one specialised centre (Leicester) as part of a large (> 30,000 subject) meta-analysis
study [11].
Statistical analysis
Logistic regression analysis was used to determine the association between the three traits of
interest (joint stiffness, TJR and fibrotic conditions) and telomere length. Adjustment was
made for age, sex, BMI and smoking status. The cluster option in Stata was used to adjust for
family relatedness (as previously described [12–14]. This model provides a robust estimation
of the standard errors taking into account that the observations within families are not inde-
pendent. For the purposes of this analysis, missing data was assumed to be negative. Statistical
analysis was performed using Stata software (StataCorp, Texas, USA).
Results
The soft tissue sample comprised 9,718 twins with information on at least one trait at any
time-point (hip or knee stiffness, fibrotic condition, TJR) (Table 1). This included 287 with a
stiff joint, 762 with a fibrotic condition, 378 with TJR. The mean age of the sample was 47.2
years and 87.8% were female. Measurement of TL was available for a total of 5634 twins having
soft tissue information (58%).
Univariable analysis
Logistic regression analysis was performed with telomere length as the predictor variable
(Table 2), for each of the 7 phenotypes. Respondents reporting hip stiffness or knee stiffness
had a significant association with TL (OR 0.68, 95% CI 0.58–0.78 and OR 0.73, 95% CI 0.59–
0.89, p<0.001 and 0.002 respectively). Respondents with frozen shoulder had a significant
Table 1. Demographic characteristics of the TwinsUK sample.
Total
Total respondents 5989
Mean age 49.0 (16.5–99)
Mean BMI 25.4 (sd 4.7)
No of females 5422 (90.5%)
Stiff knee 185
Stiff hip 116
Stiff joint (total) 239
Frozen shoulder 549
Dupuytren’s contracture 19
Fibrotic condition 559
TKR 144
THR 258
TJR 300
There were no significant differences in age, BMI or sex between the zygosity groups. TKR represents total knee
replacement; THR, hip replacement; TJR, total joint (either knee or hip) replacement.
https://doi.org/10.1371/journal.pone.0190120.t001
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relationship with TL (OR 0.78 CI 0.70–0.85, p =<0.001). No association was detected between
Dupuytren’s disease and TL (OR 0.90, CI 0.65–1.25, p = 0.532). Presence of TJR (hip and
knee) did not show an association with TL (OR 0.95, CI 0.83–1.08, p = 0.42).
Discussion
Here we report a significant association between telomere length and the presence of fibrotic
joint disease in a large sample taken from the NIHR BRC TwinsUK BioResource. This suggests
that impaired telomere maintenance may contribute to the development of joint fibrosis. Cur-
rently our understanding of the pathogenesis of joint fibrosis is poorly understood and conse-
quently treatment options are severely limited. Measurement of TL by qPCR is a robust
method and these twin TL data have previously contributed to the identification of new
genetic loci associated with reduced TL in a genome-wide association study[15]. In addition
TwinsUK were one of seven independent samples to demonstrate to demonstrate a relation-
ship between TL and leptin levels [16].
Analysis of this observational study has limitations. Firstly, diagnosis of fibrotic joint dis-
ease relied on patient-reported data. However, the incidence of these conditions was found to
be similar to previous studies [6,17]. Secondly, missing data was assumed to be negative, which
may have underestimated incidence values. This biases the dataset towards the null, making
positive findings less, rather than more, likely. Finally, while the overall sample size was gener-
ous, there were few cases of Dupuytren’s compared to the other conditions, which may explain
the non-significant findings for this phenotype.
Other fibrotic conditions such as liver cirrhosis and pulmonary fibrosis have been shown to
have a genetic disposition, with mutations seen in the TERT gene responsible for telomere
maintenance and repair [18]. As a result, these patients have short telomeres, with a quantita-
tive defect in stem-cell number and a qualitative deficiency in stem-cell regeneration [9]. Sex
hormones have been shown to regulate the expression of the telomerase gene in tissue [19]
and animal models [20], and more recently, resulted in telomere elongation at 24 months in a
phase 1–2 trial [9]. Soft tissue fibrotic conditions have not previously been considered part of
this spectrum, although recent evidence suggests they are heritable [2]. It is plausible that they
share underlying genetic variants, and this work suggests that telomere shortening genetic var-
iants should be explored. Our work also provides a rationale for testing the new therapeutic
agents that attenuate telomere shortening in patients with joint fibrosing conditions.
Table 2. Results of logistic regression analyses with telomere length as the predictor, in 5634 twins.
Odds ratio Standard Error z-score p -value 95% confidence intervals
Knee stiffness 0.680 0.543 -4.83 0.000 0.581–0.795
Hip stiffness 0.728 0.076 -3.06. 0.002 0.594–0.892
Dupuytren’s 0.900 0.152 -0.63 0.532 0.645–1.254
Frozen shoulder 0.775 0.038 -5.20 0.000 0.703–0.853
TKRs 0.897 0.082 -1.18 0.237 0.749–1.074
THR 0.967 0.783 -0.41 0.682 0.826–1.082
TJR 0.947 0.064 -0.80 0.423 0.829–1.082
All analyses were age and sex and BMI adjusted, as well as taking familial relationship into account.
https://doi.org/10.1371/journal.pone.0190120.t002
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